Tickerplace logo

Tickerplace

Summit Therapeutics Inc. logo

SMMTSummit Therapeutics Inc.

SMMT Stock Price, Valuation & Chart | Summit Therapeutics Inc.

Compare
$14.630-0.74 (-4.81%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

SMMT Historical price chart

SMMT Key Stats

Market Capitalization11.67B
PE Ratio-13.06
EPS-1.12
Trading Volume4.31M
Today's High/Low15.39/14.56
Dividend Yield0.00
52 Week High/Low29.23/12.07
Shares Outstanding797.75M
SMMT Financial Statement
SMMT Analyst ratings
SMMT Analysis & performance metrics

SMMT Company profile

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America.…

SMMT Management team

Management
Mahkam Zanganeh D.D.S., M.B.A.CEO
Co-Chief Executive Officer, President & Director
Manmeet Singh Soni CPACFO
Chief Operating Officer, Chief Financial Officer & Director
Fong Clow
Chief Biometrics Officer
Shelley D. Spray
Chief Education & Brand Officer
Urte Gayko Ph.D.
Chief Regulatory, Quality & Pharmacovigilance Officer
Laura Q. M. Chow M.D.
Senior Vice President of Clinical Development
Robert W. DugganCEO
Co-Chief Executive Officer & Executive Chairman
Dame Kay Davies DBE, FRS CBE
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Total 8 executives

SMMT Frequently asked questions

What is Summit Therapeutics Inc. (SMMT) Stock Price?

Current stock price of Summit Therapeutics Inc. (SMMT) stock is $14.630. The stock price is -4.81% lower in the session. The intraday range can be seen from this page. Volume of Summit Therapeutics Inc. (SMMT) stock is 4.31M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Summit Therapeutics Inc. (SMMT) stock price going up or down today?

The stock price of Summit Therapeutics Inc. (SMMT) can change with earnings, company news, and overall market sentiment. Summit Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Summit Therapeutics Inc. stock expensive at its current price?

Whether Summit Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SMMT on this page is -13.06. EPS on this page is -1.12. Compare those figures with peers and growth expectations before deciding if the current Summit Therapeutics Inc. price is justified.

How has the stock price of Summit Therapeutics Inc. (SMMT) performed historically?

Historical performance for Summit Therapeutics Inc. (SMMT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SMMT reacted to past earnings and market events.

Should I buy Summit Therapeutics Inc. (SMMT) stock, at this price?

Buying Summit Therapeutics Inc. (SMMT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.